[
  {
    "id": "fc_exercise_testing_6967bd5f",
    "front": "PET/CT for chemotherapy response?",
    "back": "Rapid ↓ FDG uptake in first cycle identifies responders.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_f5a4deb1",
    "front": "EGFR inhibitor: PET metabolic response time?",
    "back": "Within 2 weeks predicts durable benefit.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_c18e5c45",
    "front": "PET/CT benefit: Oligoprogressive NSCLC?",
    "back": "Detects progression, guides ablative therapy, improves survival.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_efa392bd",
    "front": "Thoracoscopy diagnostic yield (malignant effusion)?",
    "back": "95% (vs. cytology 62%, biopsy 44%).",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_e56cd9e5",
    "front": "Thoracoscopy benefit for mesothelioma staging?",
    "back": "Earlier diagnosis, better histology/extent, T stage; cannot assess N stage.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_2acfc211",
    "front": "Chemo responders by PET?",
    "back": "Rapid decrease in FDG uptake (first cycle).",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_b358851a",
    "front": "EGFR inhibitor metabolic response time?",
    "back": "Within first 2 weeks.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_b8f5ea10",
    "front": "ALK inhibitors: PET/CT for progression?",
    "back": "Detects progression earlier than CT (almost half).",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_2dc54d0d",
    "front": "Thoracoscopy diagnostic yield (overall)?",
    "back": "95% for malignant pleural effusions.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_654378d2",
    "front": "Thoracoscopy for mesothelioma staging?",
    "back": "Provides T stage information.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_89aa58ca",
    "front": "EGFR inhibitors: Metabolic response timeline?",
    "back": "Within 2 weeks for durable benefit.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_a0d022a0",
    "front": "Erlotinib PET: what does it predict?",
    "back": "Progression-free and overall survival.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_dc18a8d5",
    "front": "Thoracoscopy: Malignant effusion diagnostic yield?",
    "back": "95% (vs. cytology 62%, biopsy 44%).",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_c672d459",
    "front": "PET/CT benefit: Oligoprogressive NSCLC?",
    "back": "Detects sites for ablative therapy; improves PFS/OS.",
    "difficulty": "hard",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  },
  {
    "id": "fc_exercise_testing_99f77606",
    "front": "Thoracoscopy: Mesothelioma staging info?",
    "back": "Earlier diagnosis, better histology, T stage assessment.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Exercise Testing (6MWT, CPET)",
    "bookId": "exercise_testing",
    "sourceSection": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "PART 3 – Clinical Respiratory Medicine",
      "section": "1154 PART 3 ⚫ **Clinical Respiratory Medicine**",
      "pageNumber": 78
    }
  }
]